Title: Comment submitted by James Losey Skadden Arps Slate Meagher & Flom LLP on behalf of GlaxoSmithKline (GSK)
Title: Comment submitted by James Losey Skadden Arps Slate Meagher & Flom LLP on behalf of GlaxoSmithKline (GSK) (2)
Details Information
Attachments:
Comment submitted by James Losey Skadden Arps Slate Meagher & Flom LLP on behalf of GlaxoSmithKline (GSK)
View Attachment:Comment submitted by James Losey Skadden Arps Slate Meagher & Flom LLP on behalf of GlaxoSmithKline (GSK) (2)
View Attachment:Comments
Related Documents